Gelteq Limited Ordinary Shares (GELS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Gelteq Limited Ordinary Shares (GELS) has a cash flow conversion efficiency ratio of -0.020x as of September 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-302.15K) by net assets ($15.11 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Gelteq Limited Ordinary Shares - Cash Flow Conversion Efficiency Trend (2023–2025)
This chart illustrates how Gelteq Limited Ordinary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read GELS total debt and obligations for a breakdown of total debt and financial obligations.
Gelteq Limited Ordinary Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Gelteq Limited Ordinary Shares ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Beasley Broadcast Group Inc
NASDAQ:BBGI
|
-0.035x |
|
Bioalpha Holdings Bhd
KLSE:0179
|
-0.073x |
|
Intelligent Living Application Group Inc
NASDAQ:ILAG
|
-0.157x |
|
Sersol Bhd
KLSE:0055
|
0.010x |
|
Hexicon AB
ST:HEXI
|
0.041x |
|
Rockworth Public Company Limited
BK:ROCK
|
0.109x |
|
JPMorgan Euro Small Companies Trust Plc
LSE:JEDT
|
0.026x |
|
Treasure Global Inc.
NASDAQ:TGL
|
-0.147x |
Annual Cash Flow Conversion Efficiency for Gelteq Limited Ordinary Shares (2023–2025)
The table below shows the annual cash flow conversion efficiency of Gelteq Limited Ordinary Shares from 2023 to 2025. For the full company profile with market capitalisation and key ratios, see GELS stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $15.80 Million | $-5.52 Million | -0.349x | -393.22% |
| 2024-06-30 | $15.11 Million | $-1.07 Million | -0.071x | +25.35% |
| 2023-06-30 | $18.66 Million | $-1.77 Million | -0.095x | -- |
About Gelteq Limited Ordinary Shares
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.